Protein News and Research

RSS

Proteins are complex molecules that are made up of amino acids. They can be found in every cell in the body, and carry out vital processes that keep human beings alive. Mutations in proteins can lead to a multitude of diseases, the most common being cancer.

Video interview highlights latest research developments in women’s reproductive health using Chromatrap solid state ChIP assay

An informative video interview with Professor Steve Conlan of the College of Medicine at Swansea University (UK) highlights the latest research developments in women’s reproductive health using unique molecular biology tools.

From Chromatrap® - Porvair Sciences Ltd 30 Jun 2014

Light-sensitive molecule enables noninvasive silencing of neurons

Optogenetics, a technology that allows scientists to control brain activity by shining light on neurons, relies on light-sensitive proteins that can suppress or stimulate electrical signals within cells. This technique requires a light source to be implanted in the brain, where it can reach the cells to be controlled.

30 Jun 2014

Increasing clearance of ALS misfolded protein from neurons improves their survival

In work supported by The ALS Association, researchers have shown that increasing the clearance of misfolded protein from neurons improves their survival. The study was published today in the journal Nature Chemical Biology.

30 Jun 2014

Host-directed therapy: A new type of TB treatment

In a new study published in Nature, scientists describe a new type of tuberculosis (TB) treatment that involves manipulating the body's response to TB bacteria rather than targeting the bacteria themselves, a concept called host-directed therapy.

28 Jun 2014

Targeting ASIC-related neurotransmission may lead to new therapies for treating drug addiction

University of Iowa researchers have discovered a new form of neurotransmission that influences the long-lasting memory created by addictive drugs, like cocaine and opioids, and the subsequent craving for these drugs of abuse. Loss of this type of neurotransmission creates changes in brains cells that resemble the changes caused by drug addiction.

28 Jun 2014

Lassa virus uses two-step process to invade cells, shows study

Scientists have discovered that the Lassa virus, which is endemic to West Africa, uses an unexpected two-step process to enter cells.

28 Jun 2014

Newly identified compound may halt progression of Alzheimer's disease

Without a steady supply of blood, neurons can't work. That's why one of the culprits behind Alzheimer's disease is believed to be the persistent blood clots that often form in the brains of Alzheimer's patients, contributing to the condition's hallmark memory loss, confusion and cognitive decline.

28 Jun 2014

Some cancer patients with aggressive tumors may benefit from anti-inflammatory drugs

New research raises the prospect that some cancer patients with aggressive tumors may benefit from a class of anti-inflammatory drugs used to treat rheumatoid arthritis.

28 Jun 2014

Vertex receives positive opinion from European CHMP for approval of KALYDECO for cystic fibrosis

Vertex Pharmaceuticals Incorporated today announced that the European Committee for Medicinal Products for Human Use has issued a positive opinion recommending the approval of KALYDECO (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have one of eight non-G551D gating mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

28 Jun 2014

Viewpoints: ObamaCare and economic growth; involving judiciary in political disputes

Financial markets shrugged off Wednesday's punch-in-the-stomach report that first quarter GDP shrank by 2.9% on an annual basis, far more than earlier estimates and the worst quarterly decline in five years. Optimists blame the weather and point to faster growth in the current quarter, which is reasonable but still shouldn't overlook ObamaCare's role in nearly sending the economy back into recession.

27 Jun 2014

Dosing commences in Essentialis’ DCCR clinical study in obese Prader-Willi syndrome patients

Essentialis announced today the dosing of the first patient in clinical study PC025, which is designed to evaluate the safety and efficacy of diazoxide choline controlled release tablets (DCCR) in obese Prader-Willi syndrome patients.

27 Jun 2014

ASPIRE completes patient enrollment in Phase III trial of vaginal ring for HIV prevention

ASPIRE, one of two Phase III trials of a promising method for preventing HIV in women - a vaginal ring worn for a month at a time - has completed enrollment of participants, with 2,629 women from 15 clinical research sites in Malawi, South Africa, Uganda and Zimbabwe now taking part in the study.

27 Jun 2014

Personalized antibiotic therapy can help fight antibiotic-resistant infections

The Centers for Disease Control and Prevention warned last fall that the U.S. faces "potentially catastrophic consequences" if it doesn't act quickly to combat the growing threat of antibiotic-resistant infections, which kill about 23,000 Americans a year.

27 Jun 2014

Cancer drug shows promise in treating blood cell disorders

Scientists working to make gene therapy a reality have solved a major hurdle: how to bypass a blood stem cell's natural defenses and efficiently insert disease-fighting genes into the cell's genome.

27 Jun 2014

Interactions with other infections can trigger herpes virus to reactivate, shows research

The famous slogan is "A diamond is forever," but that phrase might be better suited to herpes: Unlike most viruses, which succumb to the immune system's attack, herpes remains in the body forever, lying in wait, sometimes reactivating years later.

27 Jun 2014

ONCOblot test identifies ENOX2 cancer marker, paves way for minimally invasive tests

Cancer is rarely black and white, and it's no small matter no matter how small, but a new discovery in the field of cancer screenings has come to light that signals a shift to an earlier, more certain and specific cancer diagnosis.

27 Jun 2014

Neuroscientists can control muscle movement by applying optogenetics

For the first time, MIT neuroscientists have shown they can control muscle movement by applying optogenetics - a technique that allows scientists to control neurons' electrical impulses with light - to the spinal cords of animals that are awake and alert.

27 Jun 2014

Scientists report first successful step toward vaccine that targets mutation in brain cancer

Astrocytomas and oligodendrogliomas are subtypes of a brain cancer called 'glioma'. These incurable brain tumors arise from glial cells, a type of support cell found in the central nervous system.

26 Jun 2014

FMM supports research project to investigate mitochondria-targeted therapeutic approach

The Foundation for Mitochondrial Medicine announced today that it is working with The Michael J. Fox Foundation for Parkinson's Research to support a research project led by Wolfdieter Springer, PhD, at the Department of Neuroscience at Mayo Clinic in Florida to investigate a mitochondria-targeted therapeutic approach to treating Parkinson's disease.

26 Jun 2014

Biologists develop new method to investigate cell surface's organization on nanometer scale

After a ten-year effort, Prof. Dr. Michael Reth from the Institute of Biology III of the University of Freiburg and the Max Planck Institute of Immunobiology and Epigenetics has developed a method to investigate the cell surface's organization on a nanometer scale.

26 Jun 2014

Protein News and Research

Further Reading

Video interview highlights latest research developments in women’s reproductive health using Chromatrap solid state ChIP assay

Light-sensitive molecule enables noninvasive silencing of neurons

Increasing clearance of ALS misfolded protein from neurons improves their survival

Host-directed therapy: A new type of TB treatment

Targeting ASIC-related neurotransmission may lead to new therapies for treating drug addiction

Lassa virus uses two-step process to invade cells, shows study

Newly identified compound may halt progression of Alzheimer's disease

Some cancer patients with aggressive tumors may benefit from anti-inflammatory drugs

Vertex receives positive opinion from European CHMP for approval of KALYDECO for cystic fibrosis

Viewpoints: ObamaCare and economic growth; involving judiciary in political disputes

Dosing commences in Essentialis’ DCCR clinical study in obese Prader-Willi syndrome patients

ASPIRE completes patient enrollment in Phase III trial of vaginal ring for HIV prevention

Personalized antibiotic therapy can help fight antibiotic-resistant infections

Cancer drug shows promise in treating blood cell disorders

Interactions with other infections can trigger herpes virus to reactivate, shows research

ONCOblot test identifies ENOX2 cancer marker, paves way for minimally invasive tests

Neuroscientists can control muscle movement by applying optogenetics

Scientists report first successful step toward vaccine that targets mutation in brain cancer

FMM supports research project to investigate mitochondria-targeted therapeutic approach

Biologists develop new method to investigate cell surface's organization on nanometer scale

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News